Cryptococcosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 18: Line 18:
{{CMG}}
{{CMG}}


==Overview==
==[[Cryptococcosis overview|Overview]]==
'''Cryptococcosis''' is an infection acquired by inhalation of soil contaminated with the encapsulated yeast ([[fungus]]) [[Cryptococcus neoformans]].
 
==[[Cryptococcosis historical perspective|Historical Perspective]]==
 
==[[Cryptococcosis pathophysiology|Pathophysiology]]==
 
==[[Cryptococcosis epidemiology and demographics|Epidemiology & Demographics]]==
 
==[[Cryptococcosis risk factors|Risk Factors]]==
 
==[[Cryptococcosis screening|Screening]]==
 
==[[Cryptococcosis causes|Causes]]==
 
==[[Cryptococcosis differential diagnosis|Differentiating Cryptococcosis]]==
 
==[[Cryptococcosis natural history|Complications & Prognosis]]==
 
==Diagnosis==
[[Cryptococcosis history and symptoms|History and Symptoms]] | [[Cryptococcosis physical examination|Physical Examination]] | [[Cryptococcosis staging|Staging]] | [[Cryptococcosis laboratory tests|Laboratory tests]] | [[Cryptococcosis electrocardiogram|Electrocardiogram]]  | [[Cryptococcosis x ray|X Rays]] | [[Cryptococcosis CT|CT]] | [[Cryptococcosis MRI|MRI]] [[Cryptococcosis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Cryptococcosis other imaging findings|Other images]] | [[Cryptococcosis other diagnostic studies|Alternative diagnostics]]
 
==Treatment==
[[Cryptococcosis medical therapy|Medical therapy]] | [[Cryptococcosis surgery|Surgical options]] | [[Cryptococcosis primary prevention|Primary prevention]]  | [[Cryptococcosis secondary prevention|Secondary prevention]] | [[Cryptococcosis cost-effectiveness of therapy|Financial costs]] | [[Cryptococcosis future or investigational therapies|Future therapies]]


== Etiology and Incidence ==
== Etiology and Incidence ==

Revision as of 14:35, 3 February 2012

For patient information click here Template:DiseaseDisorder infobox

Cryptococcosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryptococcosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryptococcosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryptococcosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryptococcosis

CDC on Cryptococcosis

Cryptococcosis in the news

Blogs on Cryptococcosis

Directions to Hospitals Treating Cryptococcosis

Risk calculators and risk factors for Cryptococcosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes

Differentiating Cryptococcosis

Complications & Prognosis

Diagnosis

History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics

Treatment

Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies

Etiology and Incidence

Cryptococcosis is a defining opportunistic infection for AIDS, although patients with Hodgkin's or other lymphomas or sarcoidosis or those receiving long-term corticosteroid therapy are also at increased risk.

Distribution is worldwide. The prevalence of cryptococcosis has been increasing over the past 20 years for many reasons, including the increase in indicence of AIDS and the expanded use of immunosuppressive drugs.

In humans, C. neoformans causes three types of infections:

Cryptococcal meningitis (infection of the brain) is believed to result from dissemination of the fungus from either an observed or unappreciated pulmonary infection. Cryptococcus gattii causes infections in immunocompetent people (those having a functioning immune system), but C. neoformans v. grubii, and v. neoformans usually only cause clinically evident infections in persons who have some form of defect in their immune systems (immunocompromised persons). People who have defects in their cell-mediated immunity, for example, people with AIDS, are especially susceptible to disseminated cryptococcosis. Cryptococcosis is often fatal, especially if untreated.

Diagnosis

Symptoms include chest pain, dry cough, swelling of abdomen, headache, blurred vision and confusion. Although symptoms may not be able to be detected.

Detection of cryptococcal antigen (capsular material) by culture of CSF, sputum and urine provides definitive diagnosis. Blood cultures may be positive in heavy infections.

Cerebrum: Cryptococcosis (PAS stain)

<youtube v=ZG0AcmtBLe4/>

Treatment

The standard regimen of treatment in non-AIDS patients intravenous Amphotericin B combined with oral flucytosine.

AIDS patients often have a reduced response to Amphotericin B and flucytosine, therefore after initial treatment as above, oral fluconazole can be used.

External links

Template:Mycoses ca:Criptococcosi


Template:WikiDoc Sources